| 25-hydroxyvitamin D | 268 |
| 25(OH)D | 152 |
| Acute respiratory distress | 128 |
| Adult obesity | 152 |
| Adult patient | 164 |
| Adverse events | 103 |
| Ambulance | 110 |
| Ameloblastoma | 327 |
| Amputation | 54 |
| Anaphylaxis | 274 |
| Angioedema | 274 |
| Angiotensin II | 136 |
| Anti-inflammatory drug therapy | 204 |
| Anti-vaccination | 285, 287 |
| Anti-vaxxer | 285 |
| Antioxidant capacity | 189 |
| Anxiety | 169 |
| Atherogenic index of plasma | 240 |
| Atherosclerosis | 240 |
| Axial spondyloarthritis | 301 |
| Bacteremia | 117 |
| Bardet-Biedl syndrome | 144 |
| Barriers | 12 |
| Bath Ankylosing Spondylitis Disease Activity Index | 301 |
| Bioethics | 287 |
| Birth time | 73 |
| Blood | 208 |
| Body composition | 152 |
| Bone mineral densitometry | 262 |
| Brain injury | 89 |
| Bullous cellulitis | 117 |
| Caffeine | 262 |
| Candida albicans | 289 |
| Candidiasis | 289 |
| Carboplatin | 229 |
| Cardiac autonomic dysfunction | 32 |
| Cardiac resynchronization therapy | 40 |
| Cellular leiomyoma | 6 |
| Charcoal | 295 |
| Chemokine | 208 |
| Children | 201 |
| Cholelithiasis | 164 |
| Chronic kidney disease | 47 |
| Chronic pain | 169 |
| Chronic renal insufficiency | 47 |
| Clinical | 60 |
| Cone-beam computed tomography | 126 |
| Conotruncal heart anomalies | 222 |
| Constrictive pericarditis | 204 |
| Consultation | 19 |
| Contrast-induced nephropathy | 40 |
| COVID-19 | 126, 128, 169, 208, 301 |
| Cytokine | 208 |
| Dapagliflozin | 217 |
| Dens invaginatus | 159 |
| Dental anomaly | 159 |
| Denture stomatitis | 289 |
| Denudation | 235 |
| Dermatology | 19 |
| Diabetes mellitus | 248 |
| Direct-acting antiviral | 201 |
| Disease flare | 301 |
| Down syndrome | 201, 281 |
| Drug side effects | 274 |
| Dual-energy X-ray absorptiometry | 262 |
| DXA | 262 |
| Echocardiography | 320 |
| Elderly patient | 164 |
| Embryo quality | 235 |
| Emergency medical services | 110 |
| Endoscopy | 327 |
| Endothelial dysfunction | 240 |
| Endothelium | 136 |
| Epithelium-off crosslinking | 255 |
| Ethiopia | 178 |
| Etoposide | 229 |
| Fabry disease | 315 |
| Familial Mediterranean fever | 32 |
| Feasibility | 164 |
| Female urinary incontinence | 67 |
| Fertilization | 235 |
| Fetal echocardiography | 222 |
| Fetal sex | 73 |
| Gentamicin | 27 |
| Germ cell tumor testicular cancer | 229 |
| Glomerular filtration rate | 47 |
| Gluten-free diet | 268 |
| Grip strength | 248 |
| Growth factors | 1 |
| Guided bone regeneration | 1 |
| Hand disability | 248 |
| Heart failure | 40 |
| Heart rate turbulence | 32 |
| Heart rate variability | 32 |
| Hematology | 19 |
| Hepatitis C infection | 201 |
| HFNC | 128 |
| Hidradenitis suppurativa | 281 |
| High-flow nasal cannula | 128 |
| Histopathological | 60 |
| HUVECs | 136 |
| Hydrodissection | 123 |
| Hypersensitivity reaction | 274 |
| Hypo-osmolar riboflavin | 255 |
| ICSI | 235 |
| Ifosfamide | 229 |
| Immune checkpoint inhibitors | 103 |
| Immunotherapy | 103 |
| Incentives | 12 |
| Individual autonomy | 287 |
| Indomethacin | 79 |
| Inflammatory arthritis | 103 |
| Keratoconus | 255 |
| Kidney transplant patients | 315 |
| Knowledge | 12 |
| Lactobacillus | 289 |
| Laparoscopic cholecystectomy | 164 |
| Lateral incisors | 159 |
| Leiomyoma variant | 6 |
| Leiomyoma with bizarre nuclei | 6 |
| Length of disease | 84 |
| Lipoid proteinosis | 96 |
| Liver transplantation | 60 |
| Malignancy | 19 |
| Median nerve | 123 |
| Mehran risk score | 40 |
| Meta-analyses | 208 |
| Metabolic associated fatty liver disease | 240 |
| Migraine | 84 |
| Mitotically active leiomyoma | 6 |
| Mucocutaneous | 96 |
| Multinucleation | 235 |
| Multisystemic | 96 |
| Neonates | 27 |
| Neurogenic dysphagia | 89 |
| Neuroimaging | 96 |
| Neuroma | 54 |
| Neuropsychiatric | 96 |
| Neutrophilto-lymphocyte ratio | 217 |
| Nevus sebaceous Jadassohn | 197 |
| Next-generation sequencing | 144 |
| Nifedipine | 79 |
| Older adults | 47 |
| Oncology | 19 |
| Oral and dental health | 295 |
| Osteoarthritis | 248 |
| Osteopenia | 262 |
| Osteoporosis | 262 |
| Oxidative stress | 136 |
| Pain | 54 |
| Pandemics | 126 |
| Parathyroid hormone | 152 |
| Pericardiectomy | 204 |
| Periodontal regeneration | 1 |
| Peripheral arterial disease | 47 |
| Phenotype-genotype correlation | 144 |
| PISQ-12 | 67 |
| Platelet | 1 |
| PMS | 189 |
| Polymyalgia rheumatica | 103 |
| Post-COVID-19 | 301 |
| Post-term pregnancy | 73 |
| Potential stem cell donors | 12 |
| Pregnancy | 235 |
| Pregnancy outcome | 73 |
| Prenatal diagnosis | 222 |
| Preterm labor | 79 |
| Probiotics | 289 |
| Prolonged pregnancy | 73 |
| Psoriasis | 281 |
| Pulmonary artery stiffness | 320 |
| Quality of life | 67 |
| Radiography | 54 |
| Radiology | 126 |
| Radiology dentistry | 126 |
| Recurrence | 6 |
| Rehabilitation | 89 |
| Remineralization | 120 |
| Resin infiltration | 120 |
| Restless legs syndrome | 84 |
| Risk and benefits | 287 |
| Roseomonas gilardii | 117 |
| Scalp | 197 |
| Screening | 315 |
| Serum zinc level | 189 |
| Sexual function | 67 |
| Shear bond strength | 307 |
| Skin lesions | 117 |
| Sleep | 169 |
| Slippery slope arguments | 287 |
| Sodium-glucose cotransporter-2 inhibitor | 217 |
| Soft tissue root coverage | 1 |
| Stem cell donation | 12 |
| Stillbirth | 73 |
| Stroke | 89 |
| Surface roughness | 307 |
| Surface treatment | 307 |
| Surgery | 327 |
| Surgical | 60 |
| Swallow therapy | 89 |
| Syria | 110 |
| Syringocystadenoma papilliferum | 197 |
| Therapeutic drug monitoring | 27 |
| Thin cornea | 255 |
| Titanium | 307 |
| Tocolytic agents | 79 |
| Tp-e | 32 |
| Tp-e/qtc | 32 |
| Transepithelial iontophoresis-assisted cross-linking | 255 |
| Transglutaminase antibody | 268 |
| Transient constriction | 204 |
| Treatment outcome | 178 |
| Treatment success rate | 178 |
| Tuberculosis | 178 |
| Type 2 diabetes mellitus | 217 |
| Ultrasonography | 123, 222 |
| Ultrasound | 54 |
| Urban Wiethe disease | 96 |
| Vaccination | 285 |
| Variants | 144 |
| Vascular involvement | 89 |
| Vitamin D deficiency | 152, 268 |
| Vitamin D level | 320 |
| White spot lesion | 120 |
| Whitening toothpaste | 295 |
| Willingness | 12 |
